A Phase III, Prospective, Multicenter, Randomized, Controlled Trial of Neoadjuvant Transcatheter Arterial Chemoembolization (TACE) plus PD-1 Antibody (Tislelizumab) in the Locally Advanced Stomach Adenocarcinoma
Latest Information Update: 04 Dec 2020
At a glance
- Drugs Tislelizumab (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Dec 2020 New trial record